I now have comprehensive content from multiple authoritative sources. Let me compile the full, detailed DKA management guide.
Diabetic Ketoacidosis (DKA): Complete Management Guide
1. Definition & Diagnostic Criteria
DKA is the triad of:
| Feature | Threshold |
|---|
| Hyperglycemia | Serum glucose >13.9 mmol/L (250 mg/dL) |
| Ketonemia/ketonuria | Serum β-hydroxybutyrate ≥3.0 mmol/L, urine ketones 2+ or more |
| Metabolic acidosis | Arterial/venous pH <7.3, serum bicarbonate <15-18 mEq/L with elevated anion gap |
Euglycemic DKA is increasingly recognized - glucose may be only 5.5-13.9 mmol/L (100-250 mg/dL), especially in patients on SGLT-2 inhibitors. Diagnosis rests on ketosis + acidosis, not glucose level alone.
- Harrison's Principles of Internal Medicine, 22E
2. Severity Classification
| Severity | pH | Serum HCO₃ | Mental Status |
|---|
| Mild | 7.25-7.30 | 15-18 mEq/L | Normal/alert |
| Moderate | 7.00-7.25 | 10-15 mEq/L | Mildly reduced |
| Severe | <7.00 | <10-15 mEq/L | Reduced/coma |
3. Common Precipitants
Most common:
- Infection (UTI, pneumonia, cellulitis)
- Insulin non-adherence or inadequate dosing
- New-onset type 1 DM
- Acute coronary syndrome
Other precipitants:
-
CVA, pulmonary embolism, acute pancreatitis
-
Drugs: corticosteroids, SGLT-2 inhibitors, cocaine, clozapine, olanzapine, lithium, sympathomimetics, thiazides
-
Endocrinopathies: Cushing syndrome, thyrotoxicosis, acromegaly
-
Severe burns, hyperthermia, hypothermia
-
Goldman-Cecil Medicine, International Edition
4. Initial Workup
Immediate labs:
- Serum glucose, electrolytes (Na⁺, K⁺, Mg²⁺, Cl⁻, PO₄, bicarbonate)
- Serum β-hydroxybutyrate (preferred over urine ketones - more accurate)
- Venous blood gas (pH differs from arterial by only 0.03 - arterial not mandatory)
- BUN, creatinine
- CBC with differential
- Urinalysis
- Serum lactate
- Lipase (if pancreatitis suspected - amylase is unreliable in DKA as it may be of salivary origin)
- ECG (QTc prolongation common, especially in children)
- Blood cultures, CXR as clinically indicated
Lab interpretation caveats:
- Serum potassium is often normal or elevated despite profound total-body deficit - shifts out of cells due to acidosis. Initial hypokalemia = severe total-body deficit and emergency.
- Measured serum Na⁺ is factitiously low; corrected Na = measured Na + [1.6 × (glucose mg/dL - 100)/100]
- WBC elevation reflects ketosis severity more than infection (only bandemia has high sensitivity for infection)
- β-hydroxybutyrate is NOT detected by nitroprusside assay; measured ketones may appear falsely low. Paradoxical rise in measured ketones during treatment is expected as BHB converts to acetoacetate.
5. Management Protocol
Step 1: Fluid Resuscitation
Fluid deficit is typically 3-5 L in adults (up to 4-10 L in severe cases).
| Phase | Fluid | Rate |
|---|
| Initial resuscitation (shock) | 0.9% NaCl or Lactated Ringer's | Boluses of 20 mL/kg until SBP ≥80 mmHg; or 1-2 L over first 1-3 h |
| Ongoing replacement | Switch to 0.45% NaCl (or LR) | 250-500 mL/h |
| When glucose reaches 250 mg/dL | Add 5-10% dextrose in 0.45% NaCl or LR | 150-250 mL/h |
Pediatric dosing: 20 mL/kg NS in first hour; then adjust for age, cardiac status, degree of dehydration targeting urine output 1-2 mL/kg/h.
Note: Lactated Ringer's is associated with more rapid DKA resolution and less hyperchloremia than normal saline. Balanced crystalloids (e.g., Plasmalyte) also show favorable results. Large volumes of NS can worsen metabolic acidosis via hyperchloremia.
High serum osmolality: Correct fluid deficits more slowly to avoid precipitating cerebral edema (osmolality >340 mOsm/L correlates with stupor/coma).
Step 2: Insulin Therapy
Critical rule: Do NOT give insulin if K⁺ <3.3 mEq/L - correct potassium first.
Standard IV protocol:
- Bolus: 0.1 units/kg regular insulin IV
- Infusion: 0.1 units/kg/h continuous IV regular insulin
- If no response in 2-4 h: increase 2-3 fold
Subcutaneous alternative (mild-moderate DKA):
- 0.1 units/kg rapid-acting analogue SC, then 0.1 units/kg every 1 h, OR
- 0.2 units/kg every 2 h
- A 2024 meta-analysis (PMID: 39090718) confirmed SC insulin is safe and effective for mild-moderate DKA with similar time to resolution, mortality, and hypoglycemia risk compared to IV infusion, with potential reduction in length of stay.
Target glucose fall: ~50-100 mg/dL (2.8-5.6 mmol/L) per hour. Rapid fall in first 1-2 hours is mostly from volume expansion.
When glucose reaches 250 mg/dL:
- Add dextrose to IV fluids (as above) and continue insulin to close the anion gap
- Reduce infusion to 0.02-0.1 units/kg/h
- Do not stop insulin until ketoacidosis resolves (pH >7.3, HCO₃ ≥18 mEq/L, anion gap normalized)
Transition to SC insulin:
- Administer long-acting insulin as soon as patient is eating
- Overlap IV infusion and SC long-acting insulin by 2-4 hours before stopping infusion
- This reduces length of stay and facilitates transition to outpatient regimen
Step 3: Potassium Replacement
Potassium deficit averages 3-5 mEq/kg (150-250 mEq total in a 50 kg patient).
| Initial K⁺ (mEq/L) | Action |
|---|
| <3.3 | HOLD insulin. Give 10-20 mEq/h KCl IV until K⁺ ≥3.3, then start insulin |
| 3.3-3.5 | Give 10-20 mEq/h to bring K⁺ to ≥3.5 before insulin |
| 3.5-5.0 | Add 20-40 mEq KCl to each liter of IV fluid; target K⁺ 4-5 mEq/L |
| >5.0 | Start insulin, hold K⁺; recheck every 2 hours |
Continuous cardiac monitoring is mandatory - QTc prolongation is common and can cause torsades de pointes (especially in children). Avoid ondansetron and other QT-prolonging drugs.
Step 4: Other Electrolytes
Phosphate:
- Total body phosphate is depleted but routine replacement is generally not required
- Consider if symptomatic hypophosphatemia (e.g., respiratory muscle weakness, hemolytic anemia)
Magnesium:
- Correct with 1-2 g MgSO₄ if low; serum levels may not reflect body stores
Sodium:
- Corrects with fluid administration; monitor corrected sodium
Step 5: Bicarbonate
- Not routinely recommended - fluids and insulin correct the acidosis
- Consider if pH <6.9: 50-100 mEq NaHCO₃ in 400 mL sterile water + 20 mEq KCl over 2 hours
- Risks: paradoxical CNS acidosis, hypokalemia, alkalosis, delayed ketosis resolution
Step 6: Address the Precipitant
- Blood cultures, CXR, ECG, urine cultures as indicated
- Empiric antibiotics if infection suspected (do not wait for cultures in unstable patients)
- Treat ACS, consider toxicology screen
- Review medications - withhold SGLT-2 inhibitors
6. Monitoring During Treatment
| Parameter | Frequency |
|---|
| Bedside glucose | Every 1-2 hours |
| Serum electrolytes (K⁺, HCO₃⁻, PO₄) + anion gap | Every 2-4 hours for first 24 h |
| Venous blood gas / pH | Every 2-4 hours |
| Vital signs, urine output | Every 1-4 hours |
| Mental status | Continuous/hourly |
Maintain a comprehensive flow sheet tracking all of the above alongside fluid totals and insulin doses.
7. Resolution Criteria
DKA is considered resolved when ALL of the following are met:
- Glucose <200-250 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH >7.3
- Anion gap normalized (<12 mEq/L)
- Patient clinically stable and tolerating oral intake
Note: In euglycemic DKA (SGLT-2 inhibitor related), resolution is based on bicarbonate correction, not glucose normalization.
8. Complications to Monitor
| Complication | Features | Management |
|---|
| Cerebral edema | Headache, altered mental status, deteriorating consciousness, Cushing's triad. Most common in children. | Mannitol 0.5-1 g/kg IV or hypertonic saline; reduce fluid rate; ICU |
| Hypokalemia | Cardiac arrhythmias, weakness | Aggressive K⁺ replacement (see above) |
| Hypoglycemia | From excessive insulin | Add dextrose when glucose <250 mg/dL |
| Hyperchloremic acidosis | Post-treatment non-anion gap metabolic acidosis | Resolves spontaneously; use LR over NS to reduce incidence |
| Aspiration | With vomiting + altered mental status | Insert NGT; avoid oral intake until alert; consider intubation |
9. Special Situations
Pediatric DKA
- Cerebral edema is the most feared complication and the leading cause of DKA mortality in children
- Correct fluid deficits more slowly; avoid rapid osmolality shifts
- Fluid deficit 70-120 mL/kg depending on weight (Rosen's table)
- Continuous cardiac monitoring mandatory
- Outpatient management may be considered for very mild cases (pH ≥7.35, HCO₃ ≥20, tolerating fluids, reliable caregiver, no precipitant)
DKA in Pregnancy
- More severe and rapid progression; often at lower glucose levels
- Treat aggressively; obstetric consultation mandatory
- Fetal monitoring required
- Creasy & Resnik's Maternal-Fetal Medicine
SGLT-2 Inhibitor-Associated Euglycemic DKA
- Glucose often <250 mg/dL - easy to miss
- Stop SGLT-2 inhibitor
- Do NOT use glucose as the endpoint of resolution - use bicarbonate/pH
- Start dextrose infusion alongside insulin from the outset
Airway Management
- Avoid intubation if possible - patients have high respiratory drive and matching minute ventilation on the ventilator is challenging
- Intubate if comatose or unable to protect airway
- Once intubated: maintain hyperventilation to prevent worsening acidosis
10. Disposition
- ICU: Severe DKA (pH <7.0), altered mental status, hemodynamic instability, suspected cerebral edema
- Step-down/monitored unit: Mild-moderate DKA with close nursing and lab monitoring
- Discharge when: DKA resolved, tolerating oral intake, underlying precipitant treated, patient educated on sick-day rules and insulin regimen
Key References
- Harrison's Principles of Internal Medicine, 22E (2025) - Table 416-9 (Management Protocol)
- Rosen's Emergency Medicine, 9E - Box 115.1 (Treatment Summary)
- Tintinalli's Emergency Medicine - Pediatric DKA section
- Goldman-Cecil Medicine - Precipitants and pathophysiology
- Barash's Clinical Anesthesia, 9E - Perioperative DKA management
- Rodriguez Alvarez et al. (2025), Cleve Clin J Med - 2024 ADA Consensus Report review (PMID: 40032308)
- Alnuaimi et al. (2024), BMC Endocr Disord - SC vs IV insulin meta-analysis (PMID: 39090718)
2024 ADA Consensus Update highlights (PMID: 40032308): The June 2024 ADA update revised diagnostic and resolution criteria for DKA and HHS, updated assessment and management recommendations, and introduced prevention strategies. It is the first major revision in 15 years. The Cleveland Clinic review notes hospital admissions for DKA have increased considerably over the past decade.